Xanax (alprazolam) is a benzodiazepine, a class of medications that reduces abnormal excitement in the brain to produce calming, sedative effects. It is classified as a Schedule IV controlled substance by the Drug Enforcement Administration, meaning it has a recognized medical use but carries a risk of dependence and misuse.
How Benzodiazepines Work
Your brain has a natural braking system powered by a chemical messenger called GABA. Think of GABA as the signal that tells overactive nerve cells to slow down. Xanax amplifies that signal. It attaches to specific receptor sites on brain cells and makes them more responsive to GABA, so a smaller amount of GABA produces a bigger calming effect. This is why benzodiazepines are sometimes described as “positive allosteric modulators”: they don’t flip the switch on their own, but they make the switch easier to flip.
The practical result is a rapid reduction in the physical and mental symptoms of anxiety. Heart rate slows, muscle tension drops, and racing thoughts quiet down. That fast-acting relief is one reason Xanax became one of the most widely prescribed psychiatric medications in the United States, but it’s also the reason the drug carries serious risks with prolonged use.
What Xanax Is Prescribed For
The FDA has approved alprazolam for two specific conditions in adults: acute treatment of generalized anxiety disorder (GAD) and treatment of panic disorder, with or without agoraphobia. For anxiety, it is meant as a short-term tool, not a long-term solution. For panic disorder, it may be used over a somewhat longer course, though guidelines increasingly push for the shortest effective duration.
How Quickly It Works and How Long It Lasts
Xanax is considered a short-acting benzodiazepine. After you take a standard tablet, blood levels peak within one to two hours, and most people feel noticeable relief within 30 to 60 minutes. The average elimination half-life is about 11 hours, meaning it takes roughly that long for your body to clear half the dose. In practice, a single dose provides meaningful symptom relief for four to six hours before the effects taper off.
That short duration is a double-edged quality. It means the drug works fast when anxiety spikes, but it also means symptoms can resurface between doses, sometimes more intensely than before. This rebound effect is one factor that can push people toward taking higher or more frequent doses over time.
Controlled Substance Classification
The DEA places Xanax in Schedule IV, a category for drugs with a lower potential for abuse relative to Schedule III substances like certain opioid combinations. Schedule IV still means the drug is federally regulated: prescriptions typically cannot be refilled more than five times within six months, and pharmacies track dispensing carefully. Other well-known Schedule IV drugs include diazepam (Valium), lorazepam (Ativan), and zolpidem (Ambien).
Why Short-Term Use Is Emphasized
In 2020, the FDA added its strongest safety alert, a boxed warning, to all benzodiazepine labels. The warning states that these drugs should not be prescribed for long-term use because of the risks of physical dependence, tolerance (needing more of the drug for the same effect), and a paradoxical worsening of anxiety over time. A 2023 review of all known benzodiazepine prescribing guidelines found that most recommended use for fewer than four weeks. A 2025 joint clinical practice guideline classifies anything beyond 120 days of use in a year as “long-term” and notes that physical dependence can develop within weeks.
For older adults, the American Geriatrics Society lists benzodiazepines as generally inappropriate medications, with narrow exceptions for conditions like seizure disorders, alcohol withdrawal, and certain sleep disorders. This is because older adults metabolize the drug more slowly, increasing the risk of excessive sedation and falls.
Dependence and Withdrawal
Physical dependence on Xanax can develop even when the drug is taken exactly as prescribed. Because alprazolam is short-acting, rebound anxiety between doses is more common than with longer-acting benzodiazepines, and that cycle often leads to dose escalation.
Stopping Xanax abruptly after daily use of more than a month is dangerous. Withdrawal can be severe and, in rare cases, life-threatening, potentially causing seizures. The standard approach is a gradual taper supervised by a prescriber. Initial dose reductions are typically 5% to 25% of the starting dose, with further reductions at one-to-four-week intervals depending on how the person tolerates each step. The entire process often takes 8 to 12 weeks, though some people need several months. Toward the end of a taper, reductions may become extremely small because even tiny dose changes can trigger noticeable withdrawal symptoms at lower levels.
For people on high doses, prescribers sometimes cut the dose by 25% to 30% initially, then slow to 5% to 10% reductions. In complex cases, holding at a 50% reduction for several months before continuing downward can improve tolerability.
How Xanax Compares to Other Benzodiazepines
- Onset: Xanax reaches peak levels in one to two hours, similar to lorazepam but faster than clonazepam, which peaks at one to four hours.
- Duration: With an 11-hour half-life, Xanax wears off faster than diazepam (20 to 100 hours) or clonazepam (18 to 50 hours), making it useful for acute panic but less suited for all-day coverage.
- Rebound risk: Shorter-acting benzodiazepines like Xanax are more likely to produce rebound anxiety between doses, which is one reason some prescribers prefer longer-acting options for ongoing use.
An extended-release version of alprazolam (Xanax XR) exists and is designed to deliver the drug more slowly throughout the day, reducing the peaks and valleys that come with the immediate-release tablet.